SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Texas Biotech (TXB)
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: NVestor who wrote (76)3/2/1997 12:04:00 PM
From: scaram(o)uche   of 834
 
My answers to your questions (to differentiate them from *the* answers)......... (1) no, and (2) don't know if it would be used off-label, but the fear of a lawsuit would not cause such, as labeling would prevent any liability issue. You want explosive potential? Pray for the endothelin receptor antagonist.

But, to keep things simple, 3-5% of patients that need a heparin-like agent is still a nice chunk of change.

Cheers! Rick
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News